Results 191 to 200 of about 24,552 (280)
Visualization of a Bruton's Tyrosine Kinase Inhibitor Using Fluorescence and Raman Microscopy. [PDF]
Anal ChemMerchant AS +3 more
europepmc +1 more source
European Journal of Haematology, Volume 116, Issue 6, Page 771-784, June 2026.ABSTRACT Primary refractory Diffuse Large B‐Cell Lymphoma is associated with poor outcomes and limited responsiveness to conventional salvage therapies. Although CAR T‐cell therapy represents the standard of care in this setting, a substantial proportion of patients cannot receive it despite meeting disease‐related criteria. In this review, “unsuitable”
Santino Caserta +12 more
wiley +1 more source
Letter to the Editor: Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells. [PDF]
Int J Biol SciLiu M, Zhao Z.
europepmc +1 more source
ChemMedChem, Volume 21, Issue 10, 27 May 2026.This paper by Kollár et al. reports a covalent fragment linking study against the SARS‐CoV‐2 main protease (3CLPro). Beginning with inactive fragment hits, the application of rational linker design enabled the generation of reversible covalent inhibitors exhibiting low micromolar potency. The study details some general limitations and best practices of
Levente Kollár +8 more
wiley +1 more source
A case report of X-linked agammaglobulinemia complicated with necrotic pneumonia. [PDF]
Transl PediatrZhang X, Zhu J.
europepmc +1 more source
Tec regulates platelet activation by GPVI in the absence of Btk [PDF]
, 2003 Ben Atkinson +2 more
openalex +1 more source
Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations. [PDF]
Mol Ther OncolEscobar G, Maus MV.
europepmc +1 more source
Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus [PDF]
, 2012 Jack Hutcheson +10 more
openalex +1 more source